Inovio Pharmaceuticals Inc (INO)
1.89
+0.00%
Inovio Pharmaceuticals Inc (INO) is currently trading at $1.89. This represents a gain of 0% from the previous session. With a market capitalization of $0.13B, INO is a key component of the Health Care sector. Investors looking to trade INO should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade INO commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Inovio Pharmaceuticals Inc (INO) shows a bullish trend. Analysts are watching the 1.94 level closely.
Fundamentals
Mkt Cap0.13B
P/E Ratio0.0000
Volume681,334
60-Day Technical Chart
Advanced Charting
Need more indicators for INO? Use the world's #1 platform.
Open INO on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $2
| Metric |
INO +0.00% |
PLUG +1.05% |
BTBT +8.81% |
OCGN +5.53% |
|---|---|---|---|---|
| Price | $1.89 | $1.93 | $1.83 | $1.88 |
| Mkt Cap | $0.13B | $2.69B | $0.60B | $0.61B |
| - | View → | View → | View → |
Latest Headlines
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
GlobeNewswire • Feb 20, 2026
INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights
PR Newswire • Nov 10, 2025
DNA medicine developer INOVIO to present research at four events
Stock Titan • Feb 12, 2026
INO Stock Soars as FDA Backs Rolling BLA for Rare Lung Disease Drug
Nasdaq • Aug 28, 2025
Inovio Pharmaceuticals stock upgraded by Oppenheimer with $13 price target
Investing.com • Nov 11, 2025
● Gemini Agentic AI Analyst Insight for INO
Market Education
- Trump’s New Tariffs Could Push Up Kitchen Renovation Costs Sep 26, 2025
- I don't get this Dollar Cost Averaging (DCA). Explain pls Jul 18, 2023
- What do these rich Traders do - Peek into their day Jul 15, 2023
External Research